Charoenphol Pulthip, Choopong Pitipol, Sitthinamsuwan Panitta, Leeyaphan Charussri, Rujitharanawong Chuda, Boonsopon Sutasinee, Tesavibul Nattaporn, Tungsattayathitthan Usanee
Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Department of Ophthalmology, Pranangklao Hospital, Nonthaburi, Thailand.
Case Rep Ophthalmol. 2024 Jul 15;15(1):335-341. doi: 10.1159/000539723. eCollection 2024 Jan-Dec.
Syphilis exhibits a wide range of clinical presentations, mimicking various systemic and ocular diseases. Ocular syphilis, in particular, manifests with multiple presentations, ranging from anterior uveitis to panuveitis, making it a potential differential diagnosis for Behçet's uveitis. Here, we present a unique case of Behçet's panuveitis that was undergoing immunomodulatory therapy and was complicated by ocular syphilis. Notably, this case also featured rare cutaneous manifestations associated with secondary syphilis, commonly known as malignant syphilis.
A 38-year-old Thai man with refractory end-stage Behçet's panuveitis reported a maculopapular rash accompanied by increased intraocular inflammation. The escalation of immunomodulatory therapy, intended to manage the provisional diagnosis of active ocular and cutaneous Behçet's disease, resulted in clinical deterioration, with the rash transforming into multiple noduloulcerative lesions. Despite negative serologic tests for syphilis at baseline before initiating immunomodulatory therapy, syphilis infection was eventually diagnosed following reevaluation and the observation of spirochetes in a skin biopsy specimen. The patient was treated with intravenous penicillin G, resulting in an improvement in intraocular inflammation and resolution of noduloulcerative rashes.
Intraocular inflammation and mucocutaneous lesions in syphilis can mimic the presentation of Behçet's disease. The introduction of immunomodulatory therapy may alter the clinical picture, leading to a severe and atypical presentation. A high index of suspicion for reevaluating serologic tests or performing tissue biopsies is warranted for an accurate diagnosis.
梅毒临床表现多样,可模仿多种全身性和眼部疾病。特别是眼部梅毒,有多种表现形式,从前葡萄膜炎到全葡萄膜炎,这使其成为白塞氏葡萄膜炎的潜在鉴别诊断疾病。在此,我们报告一例正在接受免疫调节治疗且并发眼部梅毒的白塞氏全葡萄膜炎的独特病例。值得注意的是,该病例还具有与二期梅毒相关的罕见皮肤表现,即通常所说的恶性梅毒。
一名38岁患有难治性终末期白塞氏全葡萄膜炎的泰国男子报告出现斑丘疹皮疹,同时眼内炎症加重。旨在治疗活动性眼部和皮肤白塞氏病初步诊断的免疫调节治疗升级,导致临床病情恶化,皮疹转变为多个结节溃疡性病变。尽管在开始免疫调节治疗前基线梅毒血清学检测为阴性,但在重新评估及皮肤活检标本中观察到螺旋体后,最终诊断为梅毒感染。患者接受静脉注射青霉素G治疗,眼内炎症得到改善,结节溃疡性皮疹消退。
梅毒的眼内炎症和黏膜皮肤病变可模仿白塞氏病的表现。免疫调节治疗的引入可能改变临床症状,导致严重和非典型表现。为准确诊断,有必要高度怀疑并重新评估血清学检测或进行组织活检。